The antiplasmodial, anti-trypanosomal and anti-leishmanial activity of 25 plant extracts obtained from seven Tanzanian medicinal plants: Anncka (Enanta) kummerae (Annonaceae), Artemsa annua (Asteraceae), Pseudospondas mcrocarpa (Anacardiaceae), Drypetes natalenss (Euphorbiaceae), Acrdocarpus chloropterus (Malpighiaceae), Maytenus senegalenss (Celastraceae) and Neurautanena mts (Papilonaceae), were evaluated n vtro against Plasmodum falcparum K1, Trypanosoma bruce rhodesense STIB 900 and axenic Leshmana donovan MHOM-ET-67/82. Out of the 25 extracts tested, 17 showed good antiplasmodial activity (IC 50 0.04-5.0 µg/ml), 7 exhibited moderate anti-trypanosomal activity (IC 50 2.3-2.8 µg/ml), while 5 displayed mild anti-leishmanial activity (IC 50 8.8-9.79 µg/ml). A. kummerae, A. annua, P. mcrocarpa, D. natalenss, M. senegalenss and N. mts extracts had good antiplasmodial activity (IC 50 0.04-2.1 µg/ml) and selectivity indices (29.2-2,250 µg/ml). The high antiplasmodial, moderate anti-trypanosomal and mild anti-leishmanial activity make these plants good candidates for bioassay-guided isolation of anti-protozoal compounds which could serve as new lead structures for drug development.
Introduction
Malaria, trypanosomiasis and leishmaniasis are among the most important public health problems in developing regions (WHO, 2002) . Due to their prevalence, virulence and drug resistance status; they are the most serious and widespread parasitic diseases in the tropics (Bryceson, 1996; Marsden, 1996; Olliaro & Cattani, 1996; WHO, 2002) . In view of the complications in dealing with malaria, trypanosomiasis and leishmaniasis, chemotherapy remains a dependable cornerstone in the control of these diseases. In such efforts, plants are considered to be important sources for lead compounds owing to their successful use in the treatment of various ailments since antiquity (Sandberg & Cronlund, 1977) .
Several medicinal plants are traditionally used for the treatment of malaria and other protozoal infections in East, Central and West African countries (Akendengue & Louis, 1994; Gessler et al, 1995; Dhawahan et al, 1997; Nkeh et al, 2001 Nkeh et al, , 2003 . In 1993, Artemsa annua was introduced in Tanzania and is now widely grown in the highlands where it has become a popular remedy for malaria in the form of herbal teas and infusions (Swiss Invest Forum, 2007) . Although several phytochemical and pharmacological investigations have been done, A. annua was included to assess the efficacy of the local herbal extracts for the treatment of malaria and other protozoal diseases taking into consideration that, it is an exotic plant species growing in different soil and weather conditions. A. annua is reported to contain terpenes and flavonoids, but the endoperoxide sesquiterpene, artemisinin is the most pharmacologically useful compound reported to date.
Ethnomedical information reveals that several Anncka (formerly Enanta) species are widely used for the treatment of malaria and other ailments (Betti, 2002) . For instance Enanta chlorantha is used for the treament of malaria in West Africa (Wafo et al., 1999) . Enanta chlorantha exhibited n vvo activity against Plasmodum yoel in experimentally infected mice (Agbaje & Onabanjo, 1991) . Similarly, E. polycarpa is used for the treatment of malaria in West Africa (Bouquet & Debray, 1974) . The stembark extract of E. polycarpa showed high n vtro antiplasmodial activity against P. falcparum K1 strain (IC 50 0.126 µg/ml) and high selectivity (SI 616) (Atindehou et al., 2004) . The chemistry of E. chlorantha and E. polycarpa has been extensively studied (Leboeuf & Cave, 1972; Jössang et al., 1977a, b; Wafo et al., 1999) . The stem-bark and the leaves of E. chlorantha and E. polycarpa contain many biologically active alkaloids that are closely related. Several quinoline and isoquinoline alkaloids, including quinine and dihydroquinidine, have been isolated from E. polycarpa (Buzas et al., 1959 (Buzas et al., , 1965 . This may explain the extensive use of E. polycarpa stembark as an anti-malarial remedy in West Africa.
Pseudospondas mcrocarpa and P. longfola are used widely in African traditonal medicine (Gessler et al., 1995; Noumi & Yomi 2001) . Pseudospondas longfola is used in Gabon for reducing heart palpitation whereas P. mcrocarpa is used in Tanzania and the Democratic Republic of Congo (DRC) for the treatment of malaria and in Cameroon for constipation (Gessler et al., 1995; Noumi & Yomi 2001) . Plants in the genus Drypetes are used in African traditional medicine for the treatment of various ailments (Akendengue & Louis, 1994; Gessler et al., 1995; Nkeh et al., 2003) . Drypetes gossweler is used for the treatment of rheumatism and filariasis in Gabon (Akendengue & Louis, 1994) . Drypetes molunduana is used as a pain killer, antiinflammatory and anti-tumor drug in Cameroon (Nkeh et al., 2003) . Drypetes natalenss is used for the treatment of malaria and other ailments in Tanzania (Gessler et al., 1995) .
The tuber of Neorautanena mts is widely used as fish poison in most parts of Africa (Vongtau et al., 2000 (Vongtau et al., , 2004 Joseph et al, 2004) . N. mts contains pachyrrhizine, rotenone, 12hydroxyrotenone, neorotenone, neorautanone, neoduline, nepseudin, 4-methoxyneoduline, rautandiol A and rautandiol B.
Several Maytenus species are widely used in Africa for the treatment of malaria and other ailments (Gessler et al., 1995) . Maytenus senegalenss is commonly used for the treatment of malaria and bacterial infections in western Tanzania (Gessler et al., 1995) . The chemistry and pharmacology of Maytenus senegalenss are well documented (Hussein et al, 1999; Abraham et al., 2006) .
In our continuing efforts to validate the efficacy and safety of plants most frequently used in the treatment of malaria, we investigated the cytotoxicity and anti-protozoal activity of seven selected Tanzanian medicinal plants. We hereby report the antiplasmodial, anti-trypanosomal, anti-leishmanial and cytotoxicity activity of petroleum ether, dichloromethane and methanol extracts of Anncka (Enanta) kummerae (Annonaceae), Artemsa annua (Asteraceae), Pseudospondas mcrocarpa (Anacardiaceae), Drypetes natalenss (Euphorbiaceae), Acrdocarpus chloropterus (Malpighiaceae), Maytenus senegalenss (Celastraceae) and Neurautanena mts.
Materials and Methods

Collection and processing of plant material
The plants were collected in different parts of Tanzania in 2005 (Table 1 ). The leaves, seeds, root-bark and stem-bark were dried and powdered using pulveriser. The plant powders (500 g) were sequentially extracted with petroleum ether, dichloromethane and methanol. The extraction was done at room temperature for 48h with intermittent shaking, the solvent extract decanted and filtered off. After filtration, the solvent was removed under reduced pressure and the extracts dried further under a stream of nitrogen for 24h before being weighed and used for biological assays. In vitro assays Antiplasmodial activity was evaluated against the multi-drug resistant Plasmodum falcparum K1 strain (resistant to chloroquine and pyrimethamine), using the methods described by Matile & Pink (1990) . The parasites were maintained in a continuous n vtro culture and the quantitative assessment of n vtro antiplasmodial activity was determined by means of the microculture radioisotope technique. The inhibitory concentration (IC 50 ) represented the concentration that caused 50% inhibition in parasite growth, which was indicated by the uptake of the radio-labeled nucleic acid precursor, [ 3 H]-hypoxanthine, by P. falcparum K1 strain maintained on human red blood cells n vtro. The definition of the antiplasmodial activity used was: IC 50 < 0.5 µg/ ml -strong activity; 0.5-5.0 µg/ml -moderate activity; 5.0-10 µg/ml -mild activity and IC 50 > 10 µg/ml -inactive. Chloroquine and artemisinin (IC 50 0.063+0.03 µg/ml and 0.002+0.0001 µg/ml, respectively) were used as standards.
The n vtro antitrypanosomal activity was evaluated against Trypanosoma bruce rhodesense STIB 900 strain, using the method of Räz et al. (1997) . Minimum Essential medium (MEM) was supplemented according to Baltz et al. (1985) with 2-mercaptoethanol and 15% heat inactivated horse serum which was later added to each well on a 96-well microtiter plate. Drug dilutions together with 10 4 bloodstream forms of T. b. rhodesense STIB 900 in 50ml were added to each well and the plate incubated at 37°C under a 5% CO 2 atmosphere for 72h. Ten microliters of Alamar Blue (12.5mg rezasurin dissolved in one litre of distilled water) were then added to each well and incubation continued for a further four hours. The plate was read using a Spectramax Gemini XS microplate fluorometer (Molecular Devices Cooperation, Sunnyvale, CA, USA) at an excitation wavelength of 536nm and emission wavelength of 588nm (Räz et al., 1997) . The definition of the antitrypanosomal activity used was: IC 50 < 1.0 µg/ml -strong activity, 1.0-5.0 µg/ml -moderate activity, 5.0-10 µg/ml mild activity, and IC 50 > 10 µg/ml -inactive. Melarsoprol (IC 50 0.002+0.0001 µg/ml) was used as the standard drug.
The n vtro antileishmanial assay was carried out according to the procedure of Kaminsky et al. (1996) . Leshmana donovan MHOM-ET-67/82 strain was maintained in the Syrian golden hamster (Mesocrcetus auratus). Amastigotes were collected from the spleen of an infected hamster and grown in axenic culture at 37°C in slime mould (Dctyostelum dscodeum) (SM) medium supplemented with 10% heat inactivated foetal bovine serum (FBS) at pH 5.4 under the atmosphere of 5% CO 2 in air. 100µl of culture medium with 10 5 amastigotes from axenic culture with a serial drug dilution were seeded in 96-well microtitre plates. After 72h of incubation the plates were inspected under inverted microscope to assure growth of the controls and sterile conditions. 10µl of Alamar Blue (12.5 mg rezasurin dissolved in one litre of distilled water) were then added to each well and the plates incubated for another two hours. Miltefosine was used as the standard drug. Then the plates were read with a Spectramax Gemini XS microplate fluorometer using an excitation wavelength of 536nm and an emission wavelength of 588nm. The definition of the antileishmanial activity used was: IC 50 < 1.0 µg/ml -strong activity; 1.0 -5.0 µg/ml -moderate activity; 5.0 -10.0 µg/ml -mild activity; and IC 50 > 10 µg/ml -inactive. Miltefosine (IC 50 0.11+0.001 µg/ml) was used as the standard drug.
Cytotoxicity and drug selectivity index
The n vtro cytotoxicity assay was carried out according to the procedure described by Kaminsky et al. (1996) . Rat skeletal myoblast (L-6) cells were maintained as stock culture in RPMI 1640 medium + 10% FBS + 1% Lglutamine (200mM). 100µl of cell suspension consisting of 4x10 4 cells/ml were added into each well of columns 1 and 2, 4 and 5, 7 and 8, and 10 and 11 of a 96-well micro-titre plate (Costar TM , Corning Inc.). Cells were allowed to attach for 24h, the medium removed completely the next morning, and 100µl of fresh medium added to all wells except in row H. Four drugs were tested on one plate (drug 1 column 1-3, drug 2 column 4-6, drug 3 column 7-9 and drug 4 column 10-12). A serial dilution factor of 1:3 was used to give concentrations in the range 270-0.37µg/ml. Wells in row A served as controls wells without any drugs. The plates were incubated for 72h at 37°C in 5% CO 2 in air. Podophyllotoxin was used as the standard drug. The fluorescent dye, Alamar blue (10 μl) (Trek Diagnostic Systems, East Grinstead, UK), was added to each well and the plates incubated for another two hours. The plates were read using a fluorescence plate reader at excitation and emission wavelengths of 536 and 588 nm, respectively. The definition of the cytotoxicity used was: CC 50 < 1.0 µg/ml -high cytotoxicity; CC 50 1.0-10.0 µg/ml -moderate; CC 50 10.0-30.0 µg/ml -mild; and CC 50 > 30 µg/ml -non cytotoxic. Podophyllotoxin (CC 50 0.009+0.00003 µg/ml) was used as standard cytotoxin.
Data analysis
The antitrypanosomal assay data was transferred into a graphic programme (Softmax Pro, Molecular Devices Corporation, Sunnyvale, CA, USA) to generate sigmoidal inhibition curves from which IC 50 value for each drug was calculated. The antileishmanial assay data was transferred into a graphic programme to generate sigmoidal inhibition curves from which IC 50 value for each drug was calculated. The cytotoxicity data was analysed using the plate reader software (Softmax, Molecular Devices Corporation, Sunnyvale, CA, USA) and the CC 50 value of each drug calculated.
Results
Out of 25 plant extracts, 17 showed good activity against P. falcparum K1 strain (IC 50 ≤ 5.1 μg/ml), 3 were moderately active (IC 50 5.2-10 µg/ml) while the remaining 5 were inactive (IC 50 > 10 µg/ml) ( Table 2) . Ten extracts were of particular interest since they had IC 50 values of ≤1 μg/ml: the n-hexane extract of A. annua leaf (IC 50 0.04 µg/ml, SI > 2,250.0), the dichloromethane and methanol extracts of A. kummerae stem-bark (IC 50 0.31 µg/ml, SI 187.74 and 173.55 respectively), methanol and dichloromethane of A. kummerae root-bark (IC 50 0.35, 0.36 µg/ml and SI 175.43, 29.17, respectively), the ethanol extract of A. annua seeds (IC 50 0.65 µg/ml, >138.5), the ethanol extract of D. natalenss root-bark (IC 50 1.06 µg/ ml, SI 17.92), and ethanol extract of P. mcrocarpa root-bark (IC 50 1.13 µg/ml, SI 79.65). Others with good activity (≤ 2 μg/ml) include the ethanol extract of D. natalenss stem-bark (IC 50 1.42 µg/ml, SI 62.61), the ethanol extract of N. mts tuber (IC 50 1.52 µg/ml, SI 14.40), petroleum ether extract of A. kummerae stem-bark (IC 50 1.85 µg/ml, SI 11.89), and the ethanol extract of M. senegalenss (IC 50 2.05 µg/ml, SI >43.9). The IC 50 of the crude extracts were compared with that of the standard drugs chloroquine (IC 50 = 0.063 µg/ml) and artemisinin (IC 50 = 0.002 µg/ml). The most promising extract in this assay was the n-hexane extract of the leaves of A. annua which exhibited 0.6 fold and 20-fold activity higher than that of chloroquine and lower than that of artemisinin, respectively whereas, the methanolic leaves extract of A. kummerae showed 1.9 fold and 60.0 fold activity closer to that of chloroquine and artemisinin, respectively. The stem and roots dichloromethane and methanolic extracts of A. kummerae were also promising showing between 4.9 and 5.7 fold and 155 and 180 fold activity closer to that of chloroquine and artemisinin, respectively. The rest were comparatively far less active as compared to the standard drugs (Table 3) .
Out of 25 plant extracts, nine were inactive against T. b. rhodesense, 9 others showed weak anti-trypanosomal activity with IC 50 values ranging between 25 and 10.60 µg/ ml while seven had moderate activity (IC 50 ≤ 7.40 μg/ml) ( Table 2) . Six extracts were of particular interest since the anti-trypanosomal activity was ≤ 3 μg/ml. The methanol extract of the leaves and the dichloromethane, chloroform and ethanol extracts of stem-bark and rootbark of A. kummerae had the best activity with IC 50 values of 2.3-2.8 µg/ml and SI 3.75-26.70, followed by the methanol extract of root bark of P. mcrocarpa (IC 50 5.40 µg/ml, SI 7.26) and the petroleum ether extract of A. kummerae stembark (IC 50 7.4. µg/ml, SI 2.97). The rest of the extracts were inactive. The IC 50 values of crude extracts were compared with that of the standard drug melarsoprol (IC 50 = 0.002 µg/ml). The IC 50 values indicate that, extracts were relatively far less active as compared to the standard drug (Table 3 ).
In the antileishmanial assay, 20 out of 25 plant extracts were inactive against L. donovan amastigotes (IC 50 > 10 µg/ml) while 5 exhibited mild anti-leishmanial activity ( Table 2 ). The n-hexane extract of the leaves of A. annua was the most active extract of all with an IC 50 value of 6.40 µg/ml and SI >14.06, followed by others but with narrow selectivity, these are the: ethanol extract of N. mts tuber (IC 50 8.8 µg/ml, SI 2.59), the methanol, petroleum ether and dichloromethane extracts of A. kummerae leaves (IC 50 9.25 µg/ml, SI 3.2), stem-bark (IC 50 9.74 µg/ml, SI 2.26), and root-bark (IC 50 9.79 µg/ml, SI 1.07), respectively. Comparisons of the IC 50 of the crude extracts with the IC 50 of the standard drug miltefosine (IC 50 = 0.11 µg/ml) indicated moderate activities. The IC 50 values of crude extracts were between 58.2 and >272.7 fold lower compared to that of the standard drug. Thus, n-hexane extract of A. annua leaves (58.2 fold), ethanol extract of N. mts tuber (80.0 fold), the methanol, petroleum ether and dichloromethane extracts of A. kummerae leaves (84.1->272.7 fold), stem-bark (88.5-176.4 fold), and root-bark (89.0-132.3 fold); and the dichloromethane extract of A. chloropterus leaves (106 fold), the remaining crude extracts were comparatively far less active as compared to the standard drug (Table 3) . L -leaves, ST -stem bark, RT -root bark, S -seeds, T -tuber, PE -petroleum ether, DCM -dichloromethane, n-C 6 H 14n-hexane, MeOH -methanol, CC 50 0.009 + 0.00001 µg/ml for podophyllotoxin, IC 50 0.063+0.03 and 0.002 + 0.0001 µg/ ml for chloroquine and artemisinin, respectively, IC 50 0.002+0.0001 µg/ml for melarsoprol, IC 50 0.11+0.001 µg/ml for Miltefosine. 
Discussion
Our results show that, ten extracts presented strong to moderate antiplasmodial activity with IC 50 in between 0.04 and 2.05 µg/ml. These were the leaves and seed extracts of Artemsa annua, the leaves, stem and root bark extracts of Anncka kummerae, root and stem bark extract of Drypetes natalenss, root bark extract of Pseudospondas mcrocarpa, tuber extract of Neurautanena mts and the root bark extract of Maytenus senegalenss. All this confirms their traditional use as antimalarial plants. Our results confirmed that the methanol extracts of the leaves, stem-bark, root-bark and dichloromethane extract of the stem-bark of A. kummerae have high n vtro antiplasmodial activity against P. falcparum K1 strain (IC 50 0.12-0.36 µg/ml) and high selectivity . In addition to that, the dichloromethane and methanolic extracts of the stem and roots of A. kummerae showed IC 50 values which were between 4.9 and 5.7 fold and 155 and 180 fold closer antimalarial activity to that of chloroquine and artemisinin, respectively. However, the petroleum ether and other dichloromethane extracts exhibited moderate to mild activity (IC 50 1.85-6.70 µg/ml) and low selectivity ). An exceptional good activity (IC 50 0.36 µg/ml) and moderate selectivity (SI 29.17) was found in dichloromethane extract of the rootbark, while a moderate to mild anti-leishmanial and anti-trypanosomal activity of A. kummerae extracts were noted. Anncka kummerae is a rare plant species that has not been reported outside Tanzania and should be conserved. The antiplasmodial principles of A. kummerae are currently under investigation. The hexane extract of A. annua leaves showed the highest n vtro antiplasmodial activity (IC 50 0.04 µg/ml) and selectivity index (SI > 2,250) confirming its efficacy and safety (Tawfiq et al., 2004) . Although the cytotoxicity of hexane leaf and ethanol seed extracts are the same, the activity and selectivity of the latter are lower, suggesting reduced amount of the active principles.
P. mcrocarpa root-bark extract has high n vtro antiplasmodial activity against P. falcparum K1 strain (IC 50 1.13 µg/ml) and good selectivity (SI 79.65). Unfortunately, P. mcrocarpa showed mild anti-trypanosomal activity (IC 50 5.40 µg/ ml, SI 7.26). Similar findings have been reported from Congo Brazzaville (Mbatchi et al., 2006) . Extract of P. mcrocarpa was inactive against Leshmana donovan parasites. Stem-bark and root-bark extracts of Drypetes natalenss exhibited high n vtro antiplasmodial activity against P. falcparum K1 strain (IC 50 1.42 and 1.06 µg/ml, respectively) and good selectivity (SI 62.61 and 17.92, respectively) . Maytenus senegalenss showed moderate n vtro antiplasmodial activity against P. falcparum K1 strain (IC 50 2.05 µg/ml) and good selectivity (SI > 43.9). Unfortunately, M. senegalenss extracts were inactive against T. b. rhodesense and L. donovan, respectively. Other studies have shown that methanol extract of M. senegalenss has significant antiplasmodial activity (Gessler et al., 1995; Rukunga et al., 2009) . Neurautanena mts tuber extract exhibited high n vtro antiplasmodial activity against P. falcparum K1 strain (IC 50 1.52 µg/ml) and a moderate selectivity (SI 14.43) .
The high percentage (68%) of extracts with good antiplasmodial with moderate antitrypanosomal (20 %) and mild anti-leishmanial activity (20 %) suggests that these plants may be useful in the traditional management of malaria and other protozoal diseases. In view of the high antiplasmodial activity and good selectivity of Artemsa annua extract just 0.6 fold higher activity than chloroquine and 11.8 fold lower activity than artemisinin, and the usually envisaged ten-fold improvement in biological activity of the isolated pure compound, cost benefit analysis discourages the purification downward to the pure artemisinin compound. The crude extract is itself with enough antiplasmodial activity and the required safety to serve as an antimalarial drug. However, quality control of the crude drug/extract must be undertaken and therapeutic indices determined. The n vtro anti-protozoal activity and cytotoxicity of A. kummerae, P. mcrocarpa, and D. natalenss are being reported here for the first time, and bioassay-guided isolation of bioactive principles should be undertaken to provide new anti-parasitic drugs or lead compounds for anti-malarial anti-trypanosomal and anti-leishmanial drug development. Since Neurautanena mts is an insecticidal and a potent fish poison with moderate selectivity, this plant poses health risks to users and there is a strong need for further pharmacological investigations to elucidate its toxic potential and principles for possible evaluation and development of new insecticides.
In African communities, medicinal plants have always been used for the treatment of malaria and other ailments. However, without a scientific validation the traditional preparations cannot be integrated in "modern" medicine. This study has highlighted six promising plants for further antiplasmodial investigations, and the determination of their active constituents, with a view to rationalize and optimize their utilization.
